Researchers at Baylor College of Medicine have discovered a potential new strategy to fight back against Alzheimer’s and Parkinson’s diseases, conditions that are linked to the toxic accumulation of Tau and alpha synuclein protein clumps in the brain. The team reports that tubulin, the building block of microtubules, the cell’s internal ‘railway tracks,’ can stop Tau and alpha synuclein from forming toxic clumps and instead steer them into their normal, healthy roles. The findings support redefining tubulin, from a passive casualty of disease to an active protector against toxic protein aggregation.

Researchers at the University of Colorado Anschutz have identified a critical gap in how post-amputation pain is evaluated and treated. The study shows that pain after lower limb amputation is not a single uniform condition but a set of distinct experiences that change depending on activity level and prosthetic design. These findings could influence care strategies for the nearly two million Americans living with limb loss, a number expected to grow in the coming decades.

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.

About The Study: This cross-sectional study builds on prior evidence by documenting intersectional disparities in food insecurity persistent over 23 years despite multiple intervening policy and macroeconomic changes. As in a prior cross-sectional study, racial disparities were smaller among Supplemental Nutrition Assistance Program (SNAP)-participating households than nonparticipating households.

About The Study: In this nationwide cohort study, a postholiday weekday was associated with a significantly elevated out-of-hospital cardiac arrest incidence in South Korea, particularly after consecutive rest days and among vulnerable populations. These findings support enhanced emergency medical services preparedness, targeted public health messaging during holiday periods, and evaluation of preventive interventions for high-risk populations during postholiday transitions. 

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though prescription buprenorphine can be a life-saving treatment that relieves opioid cravings and withdrawal symptoms, adherence to the medication is low.